NXGL, US65340W1027

NXGL stock holds focus as NexGel files a quarter update

Veröffentlicht am: 23.07.2026 um 20:58 Uhr | Redaktionelle Verantwortung: Rafael Müller, Chefredakteur AD HOC NEWS

NXGL stock centers on NexGel's latest filing and market context, with the company reporting $1.3 million in Q1 2026 revenue and a $2.3 million net loss.

NXGL, US65340W1027, Illustration mit AI erstellt.
NXGL, US65340W1027, Illustration mit AI erstellt.

NexGel, Inc. (US65340W1027) reported $1.3 million in revenue for Q1 2026 and a $2.3 million net loss, while its shares trade on Nasdaq under the ticker NASDAQ: NXGL. The latest company filing dated Q1 2026 gives investors the clearest fresh reference point for NXGL stock.

Q1 revenue and loss

The quarter matters because the top line was small but measurable: $1.3 million in revenue in Q1 2026. Against that, NexGel posted a $2.3 million net loss in the same period, a gap that shows how far earnings still trail sales.

The same filing also leaves a clear comparison point on the table. Revenue was $1.3 million in Q1 2026, which gives the market a current baseline even before any new guidance or larger contract update arrives.

Cash and scale

NexGel ended Q1 2026 with $5.9 million in cash and cash equivalents, a figure that matters more when revenue is still at the low seven-figure level. That balance gives the company room to keep operating, but it also places the next quarter's cash burn in sharper focus.

On the operating side, the company also disclosed gross profit of $0.6 million in Q1 2026. That means gross profit covered only part of the quarter's operating load, which is why the net loss remained several times larger than gross profit.

What the numbers say

The combination of $1.3 million revenue, $0.6 million gross profit, and a $2.3 million net loss in Q1 2026 tells the same story from three angles. NexGel is still working through the gap between commercial scale and profitability.

For NXGL stock, the key question is not the product concept but the speed at which reported revenue can expand relative to losses. Until that changes, each quarterly update will likely matter more than broad sector sentiment.

Hydrogel business line

NexGel's hydrogel platform remains the commercial core of the company, and the latest quarter shows why the product line matters. The business is still being measured less by brand strength than by revenue conversion and cash discipline.

That makes the hydrogel line the right place to watch in future filings, because even a modest increase in sales could change the relationship between gross profit and net loss if margins improve.

NXGL stock on Nasdaq

NXGL stock is listed on Nasdaq, and the most useful market reference for investors is still the company's own quarterly numbers rather than a headline-driven move. With the latest evidence centered on Q1 2026, the stock story now hinges on whether the next report shows better revenue traction, narrower losses, or both.

NXGL fact box

  • Company: NexGel, Inc.
  • ISIN: US65340W1027
  • Ticker: NASDAQ: NXGL
  • Trading venue: Nasdaq
  • Sector / Industry: Health Care / Biotechnology
  • Index membership: Not disclosed in the available company data
  • Next earnings date: 12 November 2026

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf- oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

de | US65340W1027 | NXGL | boerse | 69855859 | bgmi